title: Aspergillus-induced discitis. A role for itraconazole in therapy?
authors.affiliation: Department of Infectious Diseases, Royal Canberra Hospital South, Australian Capital Territory.
authors.forename: A
authors.initials: A
authors.lastname: McGregor
authors.forename: D
authors.initials: D
authors.lastname: McNicol
authors.forename: P
authors.initials: P
authors.lastname: Collignon
mesh_terms: D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy*; D001232:Aspergillus fumigatus / Q000302:isolation & purification*; D015299:Discitis / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery; D006801:Humans; D017964:Itraconazole; D007654:Ketoconazole / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008159:Lumbar Vertebrae; D008297:Male
chemical_list: D000935:Antifungal Agents; D017964:Itraconazole; D000666:Amphotericin B; D007654:Ketoconazole